1. Home
  2. VRDN vs GBX Comparison

VRDN vs GBX Comparison

Compare VRDN & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • GBX
  • Stock Information
  • Founded
  • VRDN 2006
  • GBX 1974
  • Country
  • VRDN United States
  • GBX United States
  • Employees
  • VRDN N/A
  • GBX N/A
  • Industry
  • VRDN Medical Specialities
  • GBX Railroads
  • Sector
  • VRDN Health Care
  • GBX Industrials
  • Exchange
  • VRDN Nasdaq
  • GBX Nasdaq
  • Market Cap
  • VRDN 1.3B
  • GBX 1.4B
  • IPO Year
  • VRDN N/A
  • GBX N/A
  • Fundamental
  • Price
  • VRDN $18.54
  • GBX $45.73
  • Analyst Decision
  • VRDN Strong Buy
  • GBX Hold
  • Analyst Count
  • VRDN 11
  • GBX 2
  • Target Price
  • VRDN $38.80
  • GBX $59.50
  • AVG Volume (30 Days)
  • VRDN 767.6K
  • GBX 372.5K
  • Earning Date
  • VRDN 08-06-2025
  • GBX 07-01-2025
  • Dividend Yield
  • VRDN N/A
  • GBX 2.80%
  • EPS Growth
  • VRDN N/A
  • GBX 88.14
  • EPS
  • VRDN N/A
  • GBX 7.10
  • Revenue
  • VRDN $305,000.00
  • GBX $3,533,700,000.00
  • Revenue This Year
  • VRDN N/A
  • GBX N/A
  • Revenue Next Year
  • VRDN $17,102.33
  • GBX N/A
  • P/E Ratio
  • VRDN N/A
  • GBX $6.44
  • Revenue Growth
  • VRDN 5.90
  • GBX 0.70
  • 52 Week Low
  • VRDN $9.90
  • GBX $37.77
  • 52 Week High
  • VRDN $27.20
  • GBX $71.06
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 62.06
  • GBX 44.35
  • Support Level
  • VRDN $15.68
  • GBX $44.44
  • Resistance Level
  • VRDN $19.10
  • GBX $47.70
  • Average True Range (ATR)
  • VRDN 1.01
  • GBX 1.10
  • MACD
  • VRDN 0.08
  • GBX 0.14
  • Stochastic Oscillator
  • VRDN 83.63
  • GBX 49.74

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: